^
9ms
QTX3034-001: QTX3034 in Patients With KRAS G12D Mutation (clinicaltrials.gov)
P1, N=250, Recruiting, Quanta Therapeutics | Not yet recruiting --> Recruiting
Enrollment open
|
KRAS (KRAS proto-oncogene GTPase)
|
Erbitux (cetuximab) • QTX3034
10ms
New P1 trial
|
KRAS (KRAS proto-oncogene GTPase)
|
Erbitux (cetuximab) • QTX3034